Autosomal dominant polycystic kidney disease (ADPKD) is the most common life‐
threatening, hereditary disease. The prevalence of ADPKD is more common than …

A retrospective multicentre study of 341 children with persistent/recurrent, isolated
haematuria is described. The haematuria was isolated for at least 6 months at the beginning …

Renal tubular acidosis (RTA) comprises a group of disorders in which excretion of hydrogen
ions or reabsorption of filtered HCO 3 is impaired, leading to chronic metabolic acidosis with …

Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of ESRD in
adults. There is currently no specific treatment for ADPKD, but great progress has been …

Serum potassium level is perhaps the most critical discriminant both in the classification of
renal tubular acidoses and in the design of management approaches. For the patient with …

Background: Blood pressure (BP) control is one of the most important treatments of
Autosomal dominant polycystic kidney disease (ADPKD). The comparative efficacy of …

Hypertensive patients with autosomal dominant polycystic kidney disease (ADPKD) have a
faster progression to end-stage renal disease (ESRD) than their normotensive counterparts …

Objective To compare the hypocalciuric and potential side‐effects of hydrochlorothiazide
(HCT) to indapamide (IND; a thiazide‐like drug) in patients with idiopathic hypercalciuria …

Discussion Haemodialysis patients and patients with other types of bleeding tendency are
prone to spontaneous and traumatic subdural and intracerebral haematoma. Moreover, the …

The prevalence of nephrolithiasis is considerably greater in patients with autosomal
dominant polycystic kidney disease (ADPKD) than in the general population. We evaluated …